Potassium Citrate

CHEMBL3989822 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
324.4 g/mol
LogP
Phase
4

Used to prevent kidney stones by making the urine less acidic, which reduces the formation of certain types of stones, and also used in people with kidney disease to treat a condition where the blood becomes too acidic. It helps maintain the proper balance of minerals in the body.

น้ำหนักโมเลกุล

324.4100 g/mol

TPSA

142.00 Ų

ด้านการรักษา

กลไกการออกฤทธิ์

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+]

InChI

InChI=1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3

Molecular Formula

C6H7K3O8

HBD / HBA

2 / 8

พันธะที่หมุนได้

2

อะตอมหนัก

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Used to prevent kidney stones by making the urine less acidic, which reduces the formation of certain types of stones, and also used in people with kidney disease to treat a condition where the blood becomes too acidic. It helps maintain the proper balance of minerals in the body.

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Yes, Potassium Citrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989822. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2735208. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.